This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Neurology, Other  • Oncology  • Pulmonary Diseases, Other  • Diagnosis  • Alert me on articles by topic  Social Bookmarking   What's this?

Debora Pellegrini, PD; Mariano Alejandro Quezel, PD; Julio Enrique Bruetman, PD

Arch Neurol. 2009;66(11):1422.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A 48-year-old woman with stage IIIA non–small-cell lung cancer presented with progressive hypoesthesia and weakness in her lower limbs, without pain. On examination, superficial and deep sensibilities were diminished below the T7 level, and she had a mild paraparesis with proximal predominance. Urinary and anal sphincter functions were normal. Magnetic resonance imaging of the dorsal spine showed an increase in diameter of the spinal cord, with hyperintensity on T2-weighted images and gadolinium enhancement from T7 through T8. Magnetic resonance imaging of the brain and cervical spine both appeared normal, while cerebrospinal fluid testing eliminated meningeal involvement. Whole-body fluorine-18-labeled deoxyglucose–positron-emission tomography/computed tomography (18-FDG-PET/CT) showed increased uptake of FDG in the mediastinum ganglia (Figure 1, arrowheads) and in the spinal cord at the T8 level (Figure 1 and Figure 2, arrows), compatible with intramedullary spinal cord metastasis . . . [Full Text of this Article]

COMMENT


AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?